News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncternal Therapeutics Inc
(NQ:
ONCT
)
4.745
+0.240 (+5.34%)
Streaming Delayed Price
Updated: 3:02 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oncternal Therapeutics Inc
< Previous
1
2
3
4
Next >
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Insiders Buying Westlake Chemical Partners And 2 Other Stocks
April 02, 2024
Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
Via
Benzinga
ONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
ONCT stock results show that Oncternal Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: Oncternal Therapeutics Q4 Earnings
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
Earnings Outlook For Oncternal Therapeutics
November 08, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Oncternal Therapeutics's Earnings: A Preview
March 06, 2024
Via
Benzinga
American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday
January 29, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
December 27, 2023
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 26, 2023
Via
Benzinga
Crude Oil Rises Over 3%; US Home Prices Increase In October
December 26, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
December 26, 2023
Oncternal Therapeutics Inc (NASDAQ: ONCT) updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed
Via
Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...
Via
Benzinga
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
December 26, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.09% to 37,418.31 while the NASDAQ rose...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 26, 2023
Via
Benzinga
Promising Preclinical Results From Blood Cancer Propel Oncternal To Buy Rating
September 18, 2023
HC Wainwright has upgraded Oncternal Therapeutics Inc (NASDAQ: ONCT) to Buy from Neutral with a
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 19, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.